Nyxoah SA. | WebDisclosure

Basculer en Français

8295	Companies
114850	Keywords
55292	Articles
62440	Press releases

Home
Companies
Nyxoah SA.

BRIEF

published on 11/06/2024 at 22:10, 14 days 13 hours ago

Nyxoah publie ses résultats financiers du troisième trimestre 2024

Résultats Financiers Approbation De La FDA Situation De Trésorerie Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis
BRIEF

published on 11/06/2024 at 22:10, 14 days 13 hours ago

Nyxoah Reports Third Quarter 2024 Financial Results

Financial Results Cash Position FDA Approval Obstructive Sleep Apnea U.S. Commercialization
PRESS RELEASE

published on 11/06/2024 at 22:05, 14 days 13 hours ago

Nyxoah Reports Third Quarter Financial and Operating Results
Nyxoah SA reports third quarter financial and operating results, with FDA approval on track for Q1 2025 and strengthening of U.S. commercial team. Company fully funded until mid-2026

Financial Results FDA Approval Sleep Apnea Nyxoah U.S. Commercial Team
BRIEF

published on 10/08/2024 at 14:05, 1 month 12 days ago

Nyxoah obtient 27 millions de dollars lors d'une offre sur le marché

Financement Marché Américain Nyxoah Neuromodulation Investisseur Dans Le Secteur De La Santé
BRIEF

published on 10/08/2024 at 14:05, 1 month 12 days ago

Nyxoah Secures $27 Million in At-the-Market Offering

Financing U.S. Market Nyxoah Neuromodulation Healthcare Investor
PRESS RELEASE

published on 10/08/2024 at 14:00, 1 month 12 days ago

Nyxoah Raises $27 Million through its At-the-Market Offering
Nyxoah raises $27 million through its At-the-Market Offering, strengthening balance sheet and U.S. focus. New investment from U.S. healthcare investor

Financing At-the-market Offering Nyxoah Obstructive Sleep Apnea Healthcare Investor
BRIEF

published on 09/27/2024 at 22:35, 1 month 23 days ago

Nyxoah présente les données prometteuses de l'étude DREAM à l'ISSS 2024

Approbation De La FDA Apnée Obstructive Du Sommeil Données Cliniques Étude DREAM Stimulation Génio
BRIEF

published on 09/27/2024 at 22:35, 1 month 23 days ago

Nyxoah Presents Promising DREAM Study Data at ISSS 2024

FDA Approval Clinical Data Obstructive Sleep Apnea DREAM Study Genio Stimulation
PRESS RELEASE

published on 09/27/2024 at 22:30, 1 month 23 days ago

DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Nyxoah presents DREAM Study results at the International Surgical Sleep Society 2024 Educational Update, showing significant improvements in OSA patients treated with Genio neuromodulation therapy

Clinical Data Nyxoah Obstructive Sleep Apnea DREAM Study Neuromodulation
BRIEF

published on 09/02/2024 at 22:10, 2 months 18 days ago

Nyxoah sonne la cloche de clôture du Nasdaq tout en se préparant au lancement sur le marché américain d'un dispositif innovant contre l'apnée du sommeil

Approbation De La FDA Apnée Du Sommeil Nyxoah Lancement Sur Le Marché Américain Appareil Genio®

Accesswire

Published on 11/21/2024 at 11:30, 23 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 50 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 53 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 53 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 18 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:30, 22 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 51 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 52 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 56 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 22 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 55 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 55 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 55 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 45 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 33 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE